Insulin resistance and central nervous system (CNS) function in type 2 diabetes.
Phase of Trial: Phase IV
Latest Information Update: 23 Feb 2010
At a glance
- Drugs Nateglinide (Primary) ; Pioglitazone (Primary)
- Indications Glucose intolerance; Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 14 Dec 2007 Status changed from in porgress to completed.
- 29 Sep 2007 New trial record.